Revenue
2018
2019
2020
2021
2022
2023
2024
2025
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥21.69T | ¥20.43T | ¥16.91T | ¥14.55T | ¥13.17T | ¥14.93T | ¥15.89T | ¥15.36T | ¥11.84T | ¥9.88T | ¥7.95T | ¥8.94T | ¥8.58T | ¥10.01T | ¥12.00T |
| Research & development | ¥1.10T | ¥923.63B | ¥880.91B | ¥787.06B | ¥738.89B | ¥804.12B | ¥806.90B | ¥751.86B | ¥634.13B | ¥560.27B | ¥519.82B | ¥487.59B | ¥463.35B | ¥563.20B | ¥587.96B |
| Operating expenses | ¥20.48T | ¥19.05T | ¥16.13T | ¥13.68T | ¥12.51T | ¥14.30T | ¥15.16T | ¥14.53T | — | — | — | — | — | — | — |
| Operating income | ¥1.21T | ¥1.38T | ¥780.77B | ¥871.23B | ¥660.21B | ¥633.64B | ¥726.37B | ¥833.56B | ¥750.28B | ¥544.81B | ¥231.36B | ¥569.77B | ¥363.77B | ¥189.64B | ¥953.11B |
| EBITDAderived | ¥2.83T | ¥2.96T | ¥2.38T | ¥2.35T | ¥2.09T | ¥2.10T | ¥2.20T | ¥2.29T | ¥1.55T | ¥1.14T | ¥786.23B | ¥1.16T | ¥993.45B | ¥827.29B | — |
| Net income | ¥835.84B | ¥1.11T | ¥651.42B | ¥707.07B | ¥657.42B | ¥455.75B | ¥610.32B | ¥1.06T | ¥574.11B | ¥367.15B | ¥211.48B | ¥534.09B | ¥268.40B | ¥137.00B | ¥600.04B |
| Basic EPSper diluted share | ¥178.93 | ¥225.88 | ¥128.01 | ¥137.03 | ¥380.75 | ¥260.13 | ¥345.99 | ¥590.79 | ¥318.54 | ¥203.71 | ¥117.34 | ¥295.67 | ¥147.91 | ¥75.50 | ¥330.54 |
| Diluted EPSper diluted share | ¥178.93 | ¥225.88 | ¥128.01 | ¥137.03 | ¥380.75 | ¥260.13 | ¥345.99 | ¥590.79 | — | — | — | — | — | — | — |